{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Windtree Therapeutics, Inc."},"Symbol":{"label":"Symbol","value":"WINT"},"Address":{"label":"Address","value":"2600 KELLY ROAD,SUITE 100, WARRINGTON, Pennsylvania, 18976-3622, United States"},"Phone":{"label":"Phone","value":"+1 215 488-9300"},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Windtree Therapeutics Inc is a development-stage biotechnology company focused on developing KL4 surfactant therapies for respiratory diseases. Its technology platform includes synthetic, peptide-containing surfactant and novel drug delivery technologies that deliver aerosolized KL4 surfactants without invasive procedures. Its development program utilizing its proprietary technology platform is AEROSURF which is being developed for the treatment of respiratory distress syndrome in premature infants. It operates in the business segment of research and development of products focused on surfactant therapies for respiratory disorders and diseases, and the manufacture and commercial sales of approved products."},"CompanyUrl":{"label":"Company Url","value":"https://www.windtreetx.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Eric L. Curtis","title":"Chief Operating Officer & Senior Vice President"},{"name":"George Cox","title":"Vice President-Technical Operations"},{"name":"Steven G. Simonson","title":"Chief Medical Officer & Senior Vice President"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}